Penile Corporeal Fibrosis Complicating Papaverine Self-Injection Therapy for Erectile Impotence

2017 ◽  
Vol 15 (1-2) ◽  
pp. 134-1138
Author(s):  
H. (a) Rübben ◽  
D. (b) Vorwerk ◽  
W. (a) Lutzeyer ◽  
F.-J. (a) Deutz
1990 ◽  
Vol 8 (2) ◽  
pp. 87-89 ◽  
Author(s):  
W. F. Thon ◽  
E. Seidl ◽  
A. E. J. L. Kramer ◽  
U. Jonas

2021 ◽  
Vol 2 (1) ◽  
Author(s):  
Oswaldo Martins Rodrigues Júnior

O’GORMAN, E. C.; BROWNES, I. T. Intravernosal injection therapy for erectile impotence: moral and forensic aspects for tr eatment.  International Journal of Impotence e Research 2(2): 99-104, 1990. Resumo e Comentários de Oswaldo Martins Rodrigues Jr.


1992 ◽  
Vol 59 (1_suppl) ◽  
pp. 26-28
Author(s):  
F. Montorsi ◽  
F. Bergamaschi ◽  
G. Guazzoni ◽  
P. Consonimi ◽  
L Barbieri ◽  
...  

Forty patients with erectile impotence due to veno-occlusive dysfunction were treated with intracavernous injection of a four-drug mixture composed of: papaverine 12 mg/ml, prostaglandin E1 10 microg/ml, phentolamine 1 mg/ml and atropine 0.15 mg/ml. This vasoactive mixture guaranteed a rigid erection lasting at least 30 minutes in all cases. At the six-month follow-up, three patients discontinued the treatment due to personal reasons while the others are still on treatment and completely satisfied. Multi-drug intracavernous vasoactive injection is an effective therapy for veno-occlusive dysfunction of the cavernous bodies.


Sign in / Sign up

Export Citation Format

Share Document